166 related articles for article (PubMed ID: 8829015)
1. Cefixime in the treatment of patients with lower respiratory tract infections: results of US clinical trials.
Quintiliani R
Clin Ther; 1996; 18(3):373-90; discussion 372. PubMed ID: 8829015
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Neu HC; Chick TW
Chest; 1993 Nov; 104(5):1393-9. PubMed ID: 8222794
[TBL] [Abstract][Full Text] [Related]
3. Cefixime. A review of its therapeutic efficacy in lower respiratory tract infections.
Markham A; Brogden RN
Drugs; 1995 Jun; 49(6):1007-22. PubMed ID: 7641600
[TBL] [Abstract][Full Text] [Related]
4. Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Kafetzis DA
Eur J Clin Microbiol Infect Dis; 1994 Oct; 13(10):857-65. PubMed ID: 7889960
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of cefixime versus cefaclor in respiratory tract infections.
Dorow P
J Chemother; 1989 Aug; 1(4):257-60. PubMed ID: 2809693
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
Stefani S; Pellegrino MB; D'Amico G; Privitera A; Privitera O; Maccarrone G; Russo G; Nicoletti G
Chemotherapy; 1992; 38(1):36-45. PubMed ID: 1618002
[TBL] [Abstract][Full Text] [Related]
7. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
[TBL] [Abstract][Full Text] [Related]
8. Comparative, multicenter studies of cefixime and amoxicillin in the treatment of respiratory tract infections.
Kiani R; Johnson D; Nelson B
Am J Med; 1988 Sep; 85(3A):6-13. PubMed ID: 3048092
[TBL] [Abstract][Full Text] [Related]
9. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
Wiseman LR; Benfield P
Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility of respiratory tract pathogens in Finland to cefixime and nine other antimicrobial agents.
Lehtonen L; Huovinen P
Scand J Infect Dis; 1993; 25(3):373-8. PubMed ID: 8362234
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Stutman HR; Arguedas AG
Clin Infect Dis; 1992 Jun; 14 Suppl 2():S204-8; discussion S209-11. PubMed ID: 1617039
[TBL] [Abstract][Full Text] [Related]
12. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
Perry CM; Scott LJ
Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
[TBL] [Abstract][Full Text] [Related]
13. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
Beumer HM
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of cefixime in pediatric respiratory tract infections].
Iwai N; Nakamura H; Kasai K; Ozaki T; Matsui Y; Tauchi N; Yamaguchi H; Taneda Y; Maki T
Jpn J Antibiot; 1991 Jan; 44(1):35-47. PubMed ID: 2041146
[TBL] [Abstract][Full Text] [Related]
15. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
[TBL] [Abstract][Full Text] [Related]
16. [Controlled multicentric study comparing cefixime and amoxicillin in the treatment of lower respiratory tract infections in adults].
Hugues FC; Le Jeunne C
Presse Med; 1989 Oct; 18(32):1600-4. PubMed ID: 2530542
[TBL] [Abstract][Full Text] [Related]
17. Cefixime in the treatment of upper respiratory tract infections and otitis media.
de Lalla F
Chemotherapy; 1998 Sep; 44 Suppl 1():19-23. PubMed ID: 9797419
[TBL] [Abstract][Full Text] [Related]
18. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
[TBL] [Abstract][Full Text] [Related]
19. Cefixime in the treatment of respiratory and urinary tract infections.
Ludwig E
Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
[TBL] [Abstract][Full Text] [Related]
20. Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Sader HS; Jacobs MR; Fritsche TR
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):5S-12S. PubMed ID: 17292577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
